Cargando…
Novel curcumin derivatives as potent inhibitors of amyloid β aggregation
Modulation of abnormal amyloid β (Aβ) aggregation is considered to be a potential therapeutic target for Alzheimer’s disease (AD). Recent in vitro and in vivo experiments suggest that inhibition of Aβ aggregation by curcumin would exert favorable effects for preventing or treating AD. We have previo...
Autores principales: | Yanagisawa, Daijiro, Taguchi, Hiroyasu, Morikawa, Shigehiro, Kato, Tomoko, Hirao, Koichi, Shirai, Nobuaki, Tooyama, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669405/ https://www.ncbi.nlm.nih.gov/pubmed/29124225 http://dx.doi.org/10.1016/j.bbrep.2015.10.009 |
Ejemplares similares
-
Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer’s Disease
por: Yanagisawa, Daijiro, et al.
Publicado: (2021) -
Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5
por: Yanagisawa, Daijiro, et al.
Publicado: (2018) -
The effect of α-tocopherol, α- and γ-tocotrienols on amyloid-β aggregation and disaggregation in vitro
por: Ibrahim, Nor Faeizah, et al.
Publicado: (2021) -
Nasal Extracts from Patients with Alzheimer’s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation
por: Pahrudin Arrozi, Aslina, et al.
Publicado: (2021) -
Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
por: Tada, Asuka Matsuzaki, et al.
Publicado: (2020)